Geriatrics and HIV

Overview

CME Credit Available: 1.50 AMA PRA Category 1 Credits
Level: Advanced
Release Date: March 4, 2014
Date of Last Review/Update: January 22, 2018
Expiration Date: January 22, 2019

This Cases on the Web (COW) activity describes a case and presents various clinical decision points, each focusing on issues relevant to the care of an HIV-infected patient who has dementia.

At each decision point, participants should select the option that they think is most sound and then read the presenters’ explanation of that option. Selecting the correct option links the participant to an extended discussion of the related medical findings, research-based evidence, and case management considerations.

To advance from one clinical decision point to the next, participants should click on the NEXT button located at the bottom of the page that discusses the best clinical option.

After reviewing the cases, participants may access the activity posttest and the course evaluation, both of which must be completed and submitted to claim continuing medical education (CME) credit or a certificate of participation or continuing education units (CEUs) or nursing or pharmacy credits. Please see the posttest form and course evaluation form for further instructions.

You may sample the activity without logging in by clicking the links in the sidebar. You must be logged in the entire time in order to claim CME credit for the activity.

Learning Objectives

On completion of this activity, the learner will be able to:

  • Identify functional decline
  • Describe the spectrum of neurocognitive disorders among HIV-infected persons
  • Identify the role of a geriatrician and commonly used geriatric assessment tools
  • List alternative formulations of antiretroviral drugs

Assessment of Needs

The IAS–USA offers this state-of-the-art activity as part of a nationwide CME effort for physicians on the evolving challenges of managing HIV disease. This activity examines issues relevant to the care of an HIV-infected patient who has dementia.

Intended Audience

This enduring material is designed for physicians who are actively treating or will be treating patients with HIV infection.

This activity is also relevant for other practitioners, including nurse practitioners, nurses, physician assistants, pharmacists, and others.

CME Information

Accreditation

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The IAS–USA designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity is offered from January 22, 2018, to January 22, 2019. Physicians (MDs, DOs, and international equivalents) who successfully complete the activity posttest and submit the evaluation and registration forms are eligible to receive CME credit. Other health care practitioners will receive a Certificate of Participation.

Nursing Continuing Education Contact Hours

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 1.5 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Program expires January 22, 2019.

Pharmacy Continuing Education Contact Hours

Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.5 hours (0.15 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
UAN # 0761-9999-17-308-H02-P

Program expires January 22, 2019.

Faculty

Authors

Harjot K. Singh, MD, ScM
Dr Singh is Assistant Professor of Medicine in the Department of Infectious Diseases at Weill Cornell Medical College in New York, New York. Her clinical expertise is in the management of HIV infection. Her academic interests include HIV and aging, medical education, and quality improvement in HIV care.

Eugenia Siegler, MD
Dr Siegler is Mason Adams Professor of Geriatric Medicine at Weill Cornell Medical College in New York, New York. She is also the medical director of the inpatient geriatrics service at the Weill Cornell campus of the New York Presbyterian Hospital. Her academic interests include geriatric education and electronic health record (EHR) documentation quality.

Editors

Harry W. Lampiris, MD
Dr Lampiris is Professor of Clinical Medicine at the University of California San Francisco (UCSF), and Chief of the Infectious Diseases Section at the San Francisco Veterans Affairs Medical Center.

Meredith Greene, MD
Dr Greene is a Fellow in the Division of Geriatrics at UCSF. Her research focuses on HIV and geriatric medicine, and she is involved in the UCSF Housecalls program, which serves homebound older patients.

Collaborators

Northeast/Caribbean AIDS Education and Training Center (AETC)
This activity was developed in collaboration with the Northeast/Caribbean AETC, 1 of 8 federally funded regional centers nationwide that conducts targeted multidisciplinary HIV and AIDS education and training programs for health care practitioners. Funded by the USDHHS Health Resources and Services Administration (grant # U1OHA29291), the mission of the New York and New Jersey AETC is to assist health care professionals through education and training, to provide optimum quality services and sensitive care to HIV-infected persons, and to provide access to current information related to HIV and AIDS research and treatment. Visit the organization’s website at: http://aidsetc.org/directory/regional/northeast-caribbean-aids-education-and-training-center.

Disclosure of Financial Interests

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (ie, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

Faculty

Dr Singh has no relevant financial affiliations to disclose. (Updated 1/2/18)

Dr Siegler has received book royalties from Springer Publishing Company and has received research support from Gilead Sciences, Inc. (Updated 1/2/18)

Dr Lampiris has no relevant financial affiliations to disclose. (Updated 9/29/17)

Dr Greene has no relevant financial affiliations to disclose. (Updated 9/29/17)

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.

For our HIV effort

  • PLATINUM SUPPORTERS
    Gilead Sciences, Inc
    ViiV Healthcare
  • SILVER SUPPORTERS
    Janssen Therapeutics
    Merck

For our viral hepatitis effort

  • PLATINUM SUPPORTER
    Gilead Sciences, Inc
  • BRONZE SUPPORTER
    AbbVie
  • ADDITIONAL SUPPORT
    Merck

Cases on the Web Editorial Board

Members of the COW Editorial Board participate in a volunteer capacity. They are not compensated for their role in overseeing the program. Listed below are the COW Editorial Board members and their financial interests with commercial companies within the past 12 months from the date of disclosure. Click here to view the COW Editorial Board.

Drug and Product Disclaimer

This activity may contain information about the investigational uses of drugs or products that are not approved by the US Food and Drug Administration. Please consult full prescribing information before using any medication or product mentioned in this COW activity.

The views and opinions expressed herein are those of the faculty and do not necessarily represent the opinions or recommendations of the IAS–USA.

Contact Information

If you have any questions about this COW activity, please contact the IAS–USA:

IAS–USA
425 California Street
Suite 1450
San Francisco, CA 94104-2120
Telephone: 415-544-9400
Fax: 415-544-9401
Email: info“at”iasusa.org